Research investigating the methylation patterns of the RAD21 gene promoter in patients with chronic lymphocytic leukemia (CLL) suggests that this epigenetic modification may play a role in the development of the disease through the promotion of CLL cell self-renewal rather than by causing chromosomal abnormalities [21]. Here, RAD21 is linked to B-cell chronic lymphocytic leukemia.